Risk Factors for and Prediction Model of Skip Metastasis to Lateral Lymph Nodes in Papillary Thyroid Carcinoma

被引:19
|
作者
Hu, Daixing [1 ]
Lin, Huapeng [2 ]
Zeng, Xuan [3 ]
Wang, Tielin [4 ]
Deng, Jie [5 ]
Su, Xinliang [1 ]
机构
[1] Chongqing Med Univ, Dept Endocrine & Breast Surg, Affiliated Hosp 1, Chongqing 400016, Peoples R China
[2] Zhejiang Univ, Affiliated Hangzhou Peoples Hosp 1, Dept Intens Care Unit, Sch Med, Hangzhou 310006, Zhejiang, Peoples R China
[3] Chongqing Med Univ, Dept Oncol, Affiliated Hosp 2, Chongqing 400010, Peoples R China
[4] Third Peoples Hosp Chengdu, Dept Breast & Thyroid Surg, Chengdu 610031, Sichuan, Peoples R China
[5] Sichuan Univ, Dept Rehabil, West China Hosp, Med Ctr, Chengdu 610041, Sichuan, Peoples R China
关键词
NODAL METASTASIS; CANCER; COMPARTMENT; MANAGEMENT;
D O I
10.1007/s00268-019-05332-0
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background Cervical lymph node metastasis is a prognostic factor of papillary thyroid carcinoma (PTC). Skip metastasis (central lymph node negative and lateral lymph node positive) of PTC is not uncommon. This study aimed to retrospectively investigate the risk factors for skip metastasis in PTC and develop a prediction model for skip metastasis. Methods A total of 745 PTC patients underwent total thyroidectomy and central plus lateral lymph node dissection at the First Affiliated Hospital of Chongqing Medical University from January 2012 to December 2017. Clinicopathological characteristics were collected and analyzed. Univariate and multivariate analyses were performed to detect the risk factors for skip metastasis. A prediction model was established based on the results of multivariate analyses. Results The skip metastasis rate was 9.7% (72/745). Age > 55 years (OR 2.63, 95% CI 1.34-5.04, p = 0.004), tumor located in the upper portion (OR 4.15, 95% CI 2.30-7.63, p = 0.001), and unilaterality (OR 2.76, 95% CI 1.14-8.23, p = 0.040) were independent risk factors for skip metastasis. Clinically lymph node-negative (cN0) patients with tumor in the upper portion (24.6%, 43/175) had higher possibility of skip metastasis than those of clinically lateral lymph node-positive (cN1b) patients (5.9%, 10/169) (p = 0.001). The area under the receiver operating characteristic curve of prediction model was 0.734 and 0.740 in derivation group and validation group, respectively. However, skip metastasis was not associated with tumor-free survival rate of PTC patients (p = 0.274). Conclusion Age > 55 years, tumor located in the upper portion, and unilaterality may increase the risk of skip metastasis. We developed the first prediction model for skip metastasis based on clinicopathological parameters in PTC patients.
引用
收藏
页码:1498 / 1505
页数:8
相关论文
共 50 条
  • [41] Analysis of risk factors for lateral lymph node metastasis in papillary thyroid carcinoma: A retrospective cohort study
    Liu Qiang
    Pang Wen-ting
    Dong Yan-bo
    Wang Zhen-xiao
    Yu Ming-hang
    Huang Xue-feng
    Liu Liang-fa
    世界耳鼻咽喉头颈外科杂志英文版, 2022, 08 (03) : 274 - 278
  • [42] Risk factors for skip metastasis in patients with papillary thyroid microcarcinoma
    Wu, Xin
    Li, Binglu
    Zheng, Chaoji
    He, Xiaodong
    CANCER MEDICINE, 2023, 12 (06): : 7560 - 7566
  • [43] The clinical value of Delphian and pre-tracheal lymph nodes in predicting lateral lymph nodes metastasis of papillary thyroid carcinoma
    Huang, Chun
    Zhou, Jing
    Zhuang, Yuchen
    Xu, Tao
    Su, Xinliang
    ANNALS OF MEDICINE, 2025, 57 (01)
  • [44] Radiomics signature for prediction of lateral lymph node metastasis in conventional papillary thyroid carcinoma
    Park, Vivian Y.
    Han, Kyunghwa
    Kim, Hye Jung
    Lee, Eunjung
    Youk, Ji Hyun
    Kim, Eun-Kyung
    Moon, Hee Jung
    Yoon, Jung Hyun
    Kwak, Jin Young
    PLOS ONE, 2020, 15 (01):
  • [45] Nomograms for the prediction of lateral lymph node metastasis in papillary thyroid carcinoma: Stratification by size
    Feng, Jia-Wei
    Ye, Jing
    Hong, Li-Zhao
    Hu, Jun
    Wang, Fei
    Liu, Sheng-Yong
    Jiang, Yong
    Qu, Zhen
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [46] CUNR scoring system for the prediction of lateral lymph node metastasis in papillary thyroid carcinoma
    Lei, Jianyong
    Li, Gengpeng
    Li, Zhihui
    Rong, R. X.
    Zhu, Jingqiang
    ONCOTARGET, 2018, 9 (01) : 167 - 177
  • [47] Construction and Validation of a Prediction Model for Identifying Clinical Risk Factors of Lateral Lymph Node Metastasis in Medullary Thyroid Carcinoma
    Huang, Yizhou
    Min, Yu
    Yang, Gangyi
    Wang, Hanghang
    Yin, Guobing
    Zhang, Lili
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2022, 15 : 2301 - 2309
  • [48] A Specific Predicting Model for Screening Skip Metastasis From Patients With Negative Central Lymph Nodes Metastasis in Papillary Thyroid Cancer
    Yang, Zheyu
    Heng, Yu
    Zhao, Qiwu
    Cao, Zichao
    Tao, Lei
    Qiu, Weihua
    Cai, Wei
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [49] Lateral "Skip Metastases" in papillary Thyroid Carcinoma
    Dralle, H.
    CHIRURG, 2012, 83 (07): : 667 - 668
  • [50] Risk factors for persistent disease in papillary thyroid carcinoma with lymph node metastasis
    Oral, Aylin
    Yazici, Bulent
    Akgun, Aysegul
    Hassoy, Huer
    Ozcan, Zehra
    NUCLEAR MEDICINE COMMUNICATIONS, 2016, 37 (07) : 721 - 726